
Infectious diseases physicians and pharmacists review the 2026 IDSA guidance on antimicrobial-resistant gram-negative infections, from the rise of NDM carbapenemases and mechanism-directed therapy to DTR Pseudomonas, CRAB, and Stenotrophomonas, and share practical strategies for diagnostics, renal dosing, formulary access, laboratory readiness, and stewardship






















